Removing a blood clot from a major brain artery and injecting the clot-dissolving drug btenecteplase/b significantly improves medlinkstroke/medlink
Vous n'êtes pas connecté
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days after their stroke than those receiving standard clot removal, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2025.
Removing a blood clot from a major brain artery and injecting the clot-dissolving drug btenecteplase/b significantly improves medlinkstroke/medlink
Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors, leading to better functional outcomes.
The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an...
A new study has found that the clot-dissolving drug alteplase can significantly improve stroke recovery even when given up to 24 hours after a stroke...
Recent study presented at the American Stroke Association's International Stroke Conference 2025 suggests that the clot-dissolving medication...
A common blood pressure medication used to prevent migraines may also significantly reduce the risk of ischemic stroke in women, according to a new...
A new study suggests that people with shorter protective caps at the ends of their chromosomes, called telomeres, may have a higher risk of...
A stroke is a serious medical event that can change a person’s life in many ways, especially for older adults. It happens when blood flow to the...
Alteplase improves stroke recovery by over 50% when given up to 24 hours after symptom onset, offering hope for patients with delayed access to...